The Roundup

BioCT's weekly newsletter with the latest industry news, resources, and opportunities.

| By Kelley Gipson

The Roundup – April 11, 2024

View this email in your browser April 11, 2024 BioCT News BioCT welcomes Mike Stow of Medtronic to its Board of Directors  Member News Murphy...

| By Kelley Gipson

The Roundup – April 4, 2024

View this email in your browser April 4, 2024 Member News Ancera: The power of large language models in the poultry supply chain Following drug...

| By Kelley Gipson

The Roundup – March 28, 2024

View this email in your browser March 28, 2024 Member News Alexion adds fourth indication for C5 inhibitor Ultomiris in rare autoimmune disorder How Biohaven’s experimental obesity...

| By Kelley Gipson

The Roundup – March 6, 2024

View this email in your browser March 6, 2024 Member News Arvinas appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer Aspira Women’s Health expands senior leadership...

| By Kelley Gipson

The Roundup – March 14, 2024

View this email in your browser March 14, 2024 Member News Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of...

| By Kelley Gipson

The Roundup – March 7, 2024

View this email in your browser March 7, 2024 Member News Allyx Therapeutics announces expansion into Parkinson’s Disease clinical research with lead compound ALX-001 following IND...

| By Kelley Gipson

The Roundup – February 29, 2024

View this email in your browser February 29, 2024 Member News Arvinas moves ahead with 2 new drugs BIO: What policy biotech should be watching this election...

| By Kelley Gipson

The Roundup – February 22, 2024

View this email in your browser February 22, 2024 Member News Ancera: Monitoring system can help producers manage coccidiosis Arvinas Announces first-in-human dosing of ARV-102, an...

| By Kelley Gipson

The Roundup – February 15, 2024

View this email in your browser February 15, 2024 Member News A new class of cancer drugs is coming: Pfizer & Arvinas‘ hot pursuit of protein degrader technology...

| By Kelley Gipson

The Roundup – February 8, 2024

View this email in your browser February 8, 2024 Member News Arvinas and Pfizer’s Vepdegestrant (ARV-471) receives FDA fast track designation for the treatment of patients with...